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Abstract 
Ventilator- Associated Pneumonia VAPthat occurs in a patient connected to mechanical 
ventilation which develops 48 hours or more after initiating mechanicalventilation. The most 
common determinants of VAP in neonatal intensive care unit NICU are leukocytosis or 
Leukopenia, metabolic acidosis, Endotracheal Intubation ETT, re-intubation, and contaminated 
intensive care unit ICU environment with lack of infection control measures, administration of 
blood products, enteral feeding, , prematurity, invasive devicesand low birth weight. This study 
isa cross sectional studycontainstwo direct observation checklists designed by the researcher.The 
first observation consisted of 102 neonates(known by the first observation checklist made by the 
researcher) that admitted to NICUdistributed in four hospitals (AL- shifa Hospital "47",AL-
TahreerHospital"25", Al-Naser pediatric Hospital "21", and finally European Gaza Hospital 
EUG"9") during 100 days (period of data collection) and diagnosed with VAP. The study was 
conducted in the period from the first of May 2016 to the 10
th
of August 2016. The result of VAP 
developed in 43 of 102 ventilated neonates (42.2% VAP incidence) shows that significant 
common determinates for positive VAP were: longtime  of intubation (X
2
= 21.020; P-Value= 
0.000);ETT change times (X
2
= 6.847; P-Value= 0.033); Ryle tube (X
2
= 10.551; P-Value= 
0.001);urinary catheters (X
2
= 23.287; P-Value= 0.000); umbilical line catheter ULV (X
2
= 49.251; 
P-Value= 0.+000); chest tube (X
2
= 29.551; P-Value= 0.000); Administration of blood products 
such as plasma and packed red blood cells RBS (39.5%), plasma & human albumin &packed 
RBS (11.6%) then packed RBS (11.6), and finally plasma (4.7%) (X
2
= 14.989; P-Value= 
0.000).Blood culture resultsshow thatAcinetobacter (48.8%),Klebsilla (30.2 %),Pseudomonas 
(11.6%), and Candida (7.0%) Coagulase- negative staphylococci (2.3%) (X
2
= 54.830; P-Value= 
0.000).Mode of delivery resultsshows thatcesarean sectionCS and normal spontaneous vaginal 
delivery NSVD (X
2
= 0.220; P-Value= 0.008). The second observation was designedto observe 
four hospitals (AL- shifa Hospital"12", AL-TahreerHospital "5", Al-Naser pediatric Hospital"10", 
and finally EUG "3"). For hand washing, the results show that (F = 24,807; P-Value= 0.000); 
disinfectant tools of ETT (F = 28.539; P-Value= 0.000); infection control procedures for the 
Suction process (F = 10,851; P-Value= 0.000); infection control Polices (F = 5,774; P-Value= 
0.004); andinfection control Kits (F = 1.717; P-Value= 0.188).In conclusion, the mostimportant 
determinants of VAP are: prolonged period of intubation, placementULV,chest tube, 
inserting Ryle feeding, electiveCS delivery, transfusion anycomponent of blood 
transfusion and re-intubation ETT. Ifthese determinants are avoided or decreased, thiswill 
help in reducing the morbidity and mortality in neonates with VAP inGazagovernorates 
(GG).Moreover, Blood cultures have value in microbiological diagnosis of VAP among 
neonates butit was foundthat there were not the same microorganisms isolated 
fromBronchoalveolar LavageBAL culture. 
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Chapter (1) Introduction 
1.1 Background: 
Ventilator- Associated Pneumonia (VAP), as defined by the Centers for Disease Control 
and prevention (CDC), is a pneumonia that occurs in a patient connected to mechanical 
ventilation which develops 48 hours or more after initiation of mechanical ventilation 
(Nemat et al, 2015).VAP comes in the second stage as the most popular nosocomial 
infection through both pediatric and NICU patient (Foglia et al, 2007).VAP is classified 
into two categories, the first category is called early-onset VAP which is defined as 
pneumonia occurring within the first 5 days of mechanical ventilation. This category is 
most often antibiotic sensitive bacteria (e.g. oxacillin sensitive staphylococcus aurous, 
homophiles influenza, and streptococcuspneumonia). Then, the second category which is 
called late-onset and defined as pneumonia occurring more than 5 days of mechanical 
ventilation, this category occurs as a result of antibiotic-resistance pathogens (e.g. 
oxacillin-resistance staph aurous, pseudomonas, aeruginosa, acinetobacter  species, and 
enterobacter species) (Tang et al, 2009;Kollef et al,2015).  
The criteria used to diagnose VAP in neonates include mechanical ventilation within 48 
hours of onset of suspected VAP, worsening gas exchange with an increase in oxygen or 
ventilator requirement,two or more chest radiographs that show new infiltrates, 
consolidation, cavitations, or pneumotoceles, and at least 3 signs and symptoms. Signs and 
symptoms may include temperature instability, wheezing, tachypnea, cough, abnormal 
heart rate, change in secretions, or abnormal leukocyte count. The criteria have not been 
validated in neonates, and they are often open to subjective interpretation because they 
overlap with other disease (Badr et al, 2011). 
The diagnosis of VAP is a clinical suspicion. The most accepted clinical definition for 
suspicion of pneumonia is currently the present of pulmonary infiltrate on chest radiograph 
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plus two of the following three criteria: leukocytosis or Leukopenia, purulent respiratory 
secretions and hyperthermia or hypothermia (Fathy et al, 2013). 
The impacts of VAP are very important to be considered in the developing countries, while 
most of VAP studies were performed in developed countries. VAP is considered as a 
critical infection in health care since it results in high morbidity and mortality. Moreover it 
increases the duration of stay in hospital and rises up the costs of hospital. In developing 
countries, the measures used in preventing ventilator associated pneumonia are rarely 
recorded. Compared with adults, elder children, the neonate varies in anatomy, physiology, 
underling disease, and invasive procedures. We need urgent studies to evaluate the 
effectiveness of (VAP bundles) in NICU. The reports which are used in developing 
countries to measures success VAP intervention strategies; especially among neonates are 
rare (Azab et al, 2015). 
The pathogenesis of VAP goes through two stages the first stage is the bacterial 
colonization of the aerodigestive tract, the second stages occurs in the aspiration of 
contaminated oral secretions in the lower air ways because Endotracheal Tubes used to 
ventilate neonates are not cuffed (Badr et al, 2011). 
There is a probability from 6-20 of pneumonia to be required by the patients who need 
mechanical ventilation on the other hand patient who don’t require mechanical ventilation 
have lower probability of pneumonia infection occurrence (Tang et al, 2009). Recent 
studies have illustrated that the recurrence of VAP after cardiac surgery goes between 7% 
to 9% in adult patient and 9%to21% in pediatric. Patients in addition it leads to morbidity 
and mortality (Tang et al, 2009). 
The most common risk factors of VAP in NICU are leucopenia, thrombocytopenia, high 
C-reactive protein (CRP) metabolic acidosis, nasal Endotracheal Intubation, Re-intubation, 
prior antibiotic use, and contaminated ICU environment with lack of infection control 
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measures, use of antacids and H2 blocker, corticosteroids use, coma, use of 
sedatives/analgesics, administration of blood products, enteral feeding, low birth weight, 
prematurity and invasive devices (Badr et al, 2011; Fathy et al, 2013; Aelami et al, 2014). 
1.2 Research problem: 
Globally, the incidence of VAP in the USA ranges between 9-27% whereas in Egypt the 
incidence of VAP takes the range between 16-75%. According to the previous data, the 
incidence of VAP in developing countries is about 2.5 times higher than in the developed 
countries. So the daily risk of VAP in developed countries ranges from 1%-3% (Fathy et 
al, 2013). 
Based on what the researcher noticed; there are many cases of NICU attending 
governmental hospitals due to VAP after connected to mechanical ventilator for more than 
48 hours, those neonates are admitted to neonatal intensive care units (NICU) for several 
reasons, so the researcher found a need for determining the risk factors that lead to 
increasing the incidence of VAP in (GG). There is currently limited information about 
determinates of neonatal VAP in GG and this study will be the first to shed light on the 
role of VAP on neonatal morbidity and mortality in GG. 
1.3 Justification of the Study: 
The neonatal period "the first 28 days of life" is a highly vulnerable period during which 
many of physiological adaptations required for extra-uterine existence are completely 
found. Neonates in this period are susceptible to be infected due to his\her immature 
immune system. The inability of neonates to adjust with the extra uterine life or the 
infection of any infectious disease can lead to different health problems; one of the most 
common health problems in NICU is VAP. 
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According to many previous studies.There were no proper reporting systems for VAP in 
the developing countries, while most of reporting systems were found in the developed 
counties. 
Therefore, the researcher is interested in studying VAP in neonates ICU in GG to 
investigate the common determinants for VAP. Investigating determinates associated with 
VAP in neonates ICU is important in resolving this critical problem. Lack of studies 
concerned with VAP also motivates the researcher to highlight this problem in attempt to 
help in resolvingit.  
1.4 Study objectives 
1.4.1 General objective: 
The objective of this study is to assess the main determinates that bring about the 
development of VAP among neonates in GG. Thus, the study findings may contribute in 
assessing determines rate of neonatal VAP in ICU in Gaza governorates.   
1.4.2 Specific objectives: 
 To determine the incidence of VAP among neonates in GG. 
 To verify the relationship between invasive procedures and neonatal VAP. 
 To identify the most common determinants of VAP that haseffects on neonates. 
 To suggest recommendations for actions that could be taken to reduce the impact of 
VAP on neonate's health in ICU in GG. 
 To assess the relationship between committing to principles of infection control in 
NICU and the development of VAP in neonates. 
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1.5 Research questions: 
 Does VAP affect preterm neonates only or could affect full term and post term 
neonates? 
 What is the most common causative type of bacteria from BAL culture among 
neonates? 
 Is there an association between certain sensitivity BAL cultures laboratory results and 
occurrence of VAP? 
 Does VAP effect on low birth babies only or could affect normal birth weight babies? 
 What is the relationship between VAP and ETT re-intubation?  
 Is there a relationship between VAP and the use of the Ryle tube feeding in neonate? 
 Is there a relationship between VAP and insertion of umbilical line? 
 Is there a relationship between VAP and use the urinary catheterin neonate? 
 Is there a relationship between VAP and use the chest tubein neonate? 
1.6 Context of the study 
1.6.1 Gaza Governorate demographic characteristics 
Palestine is an Arabic Country, relatively small one, the total surface area of the historical 
Palestine is about 27.000 Km², Palestine has been occupied in1948 by Israel and the two 
remaining parts are separated geographically (West Bank and Gaza Strip) after the war in 
1967. The total area of the Gaza Strip (365Km²) and West Bank (5655 Km²) is about 
6,020 Km²with total population living in is about 4,616,418individuals (1.790.010 in GS 
and 2.826.408 WB). GS is a narrow piece of land lying in the coast of Mediterranean Sea, 
The total area of GS is about 365 Km², GS is overcrowded area with population density of 
4904 inhabitants/ Km²q (PCBS, 2014; MOH, 2014A).GS is divided into five governorates: 
Gaza Governorate, North Governorate, Mid-zone Governorate, Khan-Younis Governorate, 
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and Rafah Governorate (MOH, 2014B).According to the annual report of Ministry of 
Health in 2014, the crude birth rate (CBR) in the Palestinian territory was estimated about 
26.7/1000 of population in 2014; distributed as 23.6/1000 in the WB and 31.6/1000 in GS, 
on the other hand the crude death rate (CDR) was about 3.1/1000 of population; distributed 
as 3.8/1000 of population in GS and 2.6/1000 in WB, also the infant mortality in 2014 was 
14.3/1000 per live births in Gaza strip(MOH, 2014C). 
Moreover generally the Low Birth Weight less than 2500g was slightly enhanced from 
6.8% in 2013 to 6.3% in 2014; the babies who weigh less than 1500g decreased from 1,3% 
in 2013 to 0,4% in 2014; the babies who weigh between (1500-2000g) babies who weigh 
(2001-2500g) increased from 4,2% in 2013 to 4,5% in 2014(MOH, 2014C). 
1.6.2 Palestinian Health Care system 
Health care system in Palestine is a complex one, because the health service delivery in 
Palestine is divided into five major health care providers: two public health providers (the 
Ministry of Health and the Ministry of Interior – Military health services  ( , multiple private 
providers (hospitals, clinics) and numerous NGOs providers (the United Nations Relief and 
Works Agency-UNRWA and other local NGOs). The main provider MOH is operating 13 
hospitals and 54 clinics in GG (PCBS, 2014; MOH, 2014B). The main roles and 
responsibilities of the MOH according to the Palestinian Public Health Law are: providing, 
regulating and supervising the provision of health care in Palestine. In addition, MOH is 
responsible for planning the health care services in coordination with different 
stakeholders, enhancing health promotion to improve the health status, developing human 
resources in health sector, managing and disseminating health information, and others 
(MOH, 2014B). 
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1.6.3 Governmental Hospital Services 
MOH is the main provider of secondary care in the GS. It is responsible for 13 hospitals 
across the five governorates, the number of MOH hospital beds in the GS is about 1,680, 
and generally the total number of NICU beds is about 132; 107 beds for the MOH, 19 beds 
for NGOs, 6 beds for Military Health service. The average occupancy rate at hospitals in 
the GG is about 86.7%. The unstable Palestinian political situation increases the load on 
the health care services in Gaza and West Bank (MOH, 2014B).  
1.6.3.1 Neonatal intensive care units: 
Neonatal intensive care units are classified into two categories;  
1.6.3.1.1 The first category includesthe hospitals that have obstetrics gynecology 
department such as Al-Shifa Hospital and AL-TahreerHospital. 
First, Al-Shifa Hospital is the biggest hospital in Palestine; it is located in the west part of 
Gaza city. It was established in 1946; its NICU has been established in 1986.It contains 27 
incubators (Saleh et al, 2014). The total number of doctors in the neonatal units in Al-Shifa 
Hospital is 18 doctors:two of them are consultant, only one of them is a neonatologist, and 
16 of them are non-consultant doctors. In addition to the total number of nurses which 
forms 40 nurses, 14 nurses work at the morning shift while 7 of them work at evening 
shift, and 7 work at the night shift. There is a delivery unit in the same hospitals which 
treat its own cases and receive transferred cases from other units (GNN, 2015). 
Second, AL-TahreerHospital is located in khanyounis governorate.Its NICU has been 
established in 1989 and started with 8 incubators but now it has 14 incubators (Saleh et al, 
2014). According the Gaza Neonatal Network total number of doctors in the neonatal units 
in AL-TahreerHospital is 8 doctors, none of them isa neonatologist, and 6 of them are non-
consultant doctors, in addition to the total number of nurses which forms 17 nurses. There 
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is a delivery unit in the same hospitals which treat its own cases and receive transferred 
cases from other units (GNN, 2015). 
1.6.3.1.2 The second category includes the hospitals that receive people who seek 
medical help such as Al-Naser pediatric Hospital and European Gaza Hospital. 
The first one is Al-Naser pediatric Hospital which is located in the western part of Gaza 
city and provides several medical services for children. The hospital includes many 
departments, a nursery department which has been established in 1973 and started with 7 
incubators. In 2011 the NICU department was rehabilitated and renewed by UNICEF fund. 
Now the department becomes fully equipped and contains 33 incubators (Saleh et al, 
2014). The total number of doctors in the neonatal units in Al-Naser hospital is 12 doctors, 
one of them is a consultant doctor, and 11 of them are non-consultant doctors. In addition 
to 44 nurses, 10 of them work in the morning shift, 8 of them work at the evening shift, and 
8 of them work at the night shift. Even there are no delivery units in the same hospital, the 
hospital receives transferred cases from other unites.(Gaza Neonatal Network "GNN", 
2015). The European Gaza hospital is situated in the southern of GS and was established in 
1993. The NICU has been established at 2001 started with 20 incubators (Saleh et al, 
2014). The total number of doctors in the neonatal units in European Gaza hospital is 7 
doctors, none of them is a neonatologist-consultant doctor and 6 of them are non-
consultant doctors. In addition to the total number of nurses which forms 17 nurse, 5 of 
them work in the morning shift, 3 of them works in the evening shift, 3 of them work in the 
night shift. Even there are no delivery units in the same hospital; the hospital receives 
transferred cases from other units. (GNN, 2015). 
1.6.3.2 Levels of neonatal nurseries/unit 
The GNN classifies the clinical services role delineations for neonatology between levels 1 
to 3. Traditionally neonatal nurseries have been classified as either level 1, 2 or 3. Level 1 
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refers to routine care of babies in postnatal wards and in the NNU. Level 2 nurseries are 
located in secondary units i.e. hospitals and are providing in addition to level one care a 
low and high dependency care. Level 3, otherwise known as a Neonatal Intensive Care 
Unit (NICU) is located in a tertiary centers and provide intensive care in addition to other 
levels of care (GNN, 2015). 
1.6.3.2 .1 Level 3: Intensive neonatal care 
Level 3A: 
Care of infants of all gestational ages and weights; Mechanical ventilation support, and 
possibly inhaled nitric oxide, for as long as required immediate access to the full range of 
subspecialty consultants (GNN, 2015). 
Level 3B:  
Comprehensive on-site access to subspecialty consultants; Performance and interpretation 
of advanced imaging tests, including computed tomography, magnetic resonance imaging 
and cardiac echocardiography on an urgent basis Performance of major surgery on site but 
not extracorporeal membrane oxygenation, hemofiltration and hemodialysis, or surgical 
repair of serious congenital cardiac malformations that require cardiopulmonary bypass 
(GNN, 2015). 
Level 3C:  
Extracorporeal membrane oxygenation, hemofiltration and hemodialysis, or surgical repair 
of serious congenital cardiac malformations that require a cardiopulmonary bypass (GNN, 
2015). 
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1.7 Operational definition 
This part will includes the definition of terms included in this study 
Ventilator Association Pneumonia (VAP) 
A pneumonia where the patient is on mechanical ventilation for >2 calendar days on the 
date of event, with day of ventilator placement being day 1, and the ventilator was in place 
on the date of event or the day before (CDC, 2016).  
Mechanical ventilation 
Mechanical ventilation is an invasive life-support procedure with many effects on the 
cardiopulmonary system? In addition to equipment, requirements for this service include a 
constant supply of heated humidified oxygen, compressed air, immediate blood gas 
analysis, chest x-ray accessibility, and 24 hrs. Availability of staff capable of intubation 
and pneumothorax decompression. The presence of a ventilator alone, without proper 
support, is not sufficient for quality care (MOH, 2010). 
Pneumonia  
Neonatal pneumonia occurs perinatal or postnatal in about 1% of full term neonates and 
10% of preterm neonates. This prevalence may be as high as 28% for ventilated VLBW 
infants in the NICUs (MOH, 2010). pneumonia that can be considered are clinical signs 
and symptoms (e.g., cough, retractions, wheezing and other signs of respiratory distress, 
respiratory rate, fever, cyanosis, auscultatory findings), results of diagnostic imaging (e.g. 
chest radiograph, computed tomographic scan), and laboratory tests (microbiological 
testing for specific pathogens through serology or samples from the respiratory tract, 
inflammation markers such as white blood cell count, and differential or acute 
inflammatory markers such as C-reactive protein) (Langley, et al 2005). 
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Aged < 5 years, with pneumonia who present with cough or difficulty breathing and have 
either severe pneumonia (lower chest wall indrawing) or very severe pneumonia (central 
cyanosis, difficulty, breastfeeding/drinking, vomiting everything, convulsions, lethargy, 
unconsciousness, or head nodding) (Scott et al, 2012).  
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Chapter (2) literature review 
2. Literature review 
In this chapter the researcher reviews the critical points of the study variables that are 
related to developing VAP among neonates. In addition, the researcher reviews relevant 
previous studies and experiences of other researchers in this field. Neonatal VAP is the 
core of this study. According to the previous studies, there are several determinants' that 
may affect VAP: first, intubation profile which is classified into re-intubation and length 
period of intubation and both have a positive relationship with occurrence of VAP. Second, 
the neonatal profile which is divided into gestational age (preterm, full-term and post-term 
babies) in which the preterm babies have a positive relationship with the occurrence of 
VAP, and the birth weight (over weight, normal birth weight and LBW) in which the low 
birth weight has a positive relationship with the incidence of VAP. Third, the sensitivity of 
BAL is divided into negative and positive results, the neonates with the later results have a 
chance to be infected with VAP. Finally, invasive devises profile which includes chest 
tube, umbilical line, blood transfusion products and Ryle feeding that all increase the 
incidence of VAP if the Aseptic procedures are used. 
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2.1 Conceptual framework 
 
 
 
  
 
  
 
 
 
 
 
 
 
  
 
 
 
 
Figure 2.1: Conceptual framework diagram "self-developed" 
 
The researcher has developed the conceptual framework to address the major concepts and 
variables included in this study after reviewing the available literatures about the neonatal 
VAP. Also the researcher classified the common determinants. 
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2.1.1 Neonatal profile 
This determines include gestational age such as prematurity and post-term infant. Being a 
baby of or low birth weight or being delivered with congenital malformations, meconium 
aspiration pneumonia, congenital pneumonia and respiratory distress syndrome could be 
factors for development of VAP. Intubated neonates who developed VAP were compared 
with those who did not develop VAP with respect to post natal age, birth weight, 
prematurity (gestational ages < 37 weeks), and small for gestational age (SGA). Very low 
birth weight, and prematurity were significantly associated with VAP as observed by 
bivariate analysis (Tripathi et al, 2010). 
Not to mention the mortality rate increased in infants with a birth weight less than 1,500 g. 
Among infants who died, those with VAP had longer duration on a ventilator (13.1 vs. 4.0 
days; p<0.001) (Petdachai, 2004). 
Furthermore, the intubated neonates who developed VAP were compared with those who 
did not develop VAP with respect to post natal age, birth weight, prematurity (gestational 
ages < 37 weeks), primary diagnosis of neonate and small for gestational age (SGA). Very 
low birth weight, prematurity, were significantly associated with VAP as observed by 
bivariate analysis (Tripathi et al, 2010). 
2.1.2 Intubation profile 
Several factors may contribute to VAP in neonate. These factors include duration on MV 
stay days of neonates, re-intubation and how many to change times of ETT tube to the 
neonates (Badr et al, 2011). 
Prolonged duration of admission NICU was significant risk factor for VAP. In addition to 
prolonged duration of ventilation generally increases the risk of infection due to exposure 
to other devices such as nebulizers, humidifiers, and ventilator circuits, which have been 
proven to be important sources and media for microorganisms (Khattab et al, 2014). 
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Intubated neonates who developed VAP were compared with those who did not develop 
VAP with duration of mechanical ventilation, number of re-intubations, length of NICU 
stay, primary diagnosis of neonate duration of MV, number of re-intubations and length of 
NICU stay were significantly associated with VAP as observed by bivariate analysis 
(Tripathi et al, 2010). 
2.1.3 Invasive devices profile 
It includes conditions and events occurred during the insertion of chest tube, total 
parenteral nutrition, umbilical vein catheterization (UVC)  and insertion Ryle tube are 
considered important sources of blood stream infection in ventilated neonates (Bader et al, 
2011). 
In other study that appears risk factors for VAP. Univariate analysis indicated that the 
following were significantly associated with VAP: impaired consciousness, tracheostomy, 
re-intubation, emergency intubation, and nasogastric tube. Selected risk factors were 
entered into a logistic regression model to perform the multivariate analysis, which 
revealed that the independent risk factor for VAP were emergency intubation and 
tracheostomy (Joseph et al, 2009). 
Overall devices association infection (DAI) incidence was 8.16/100 device-used patients 
and incidence density was 9.29/1000 device days. VAP incidence was 6.6/100 ventilated 
patients and VAP rate was 13.76/1000 ventilator days. (CVC)/(UC) blood stream infection 
(BSI) incidence and rate were 1.5/1000 catheterized patients and 3.8/1000 CVC/UC days, 
respectively. During their NICU stay, 9 infants had multiple DAIs and 31 infants had a 
single episode of DAI (Yalaz et al 2012). 
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2.1.4 BAL culture and sensitivity profile 
Several studies highlight the association of positive secretions culture from 
Bronchoalveolar lavage with VAP among neonates. Many of literature shows that the most 
common causative organisms were pseudomonas aeruginosa, klebsilla, Escherichia coli, 
staphylococcus aureus, acinetobacter, candida and protes (Fathy et al, 2013). 
The results of non-bronchoscopicbronchoalveolar lavage culturesrevealed the presence of 
Klebsiellaspp. (34%), Pseudomonas spp. (25.5%), S. aureus(17%),E. coli (17%), and 
Candida spp. (6.4%). K. pneumoniaewas the most commonly isolated pathogen in non-
bronchoscopicbronchoalveolar lavage (Khattab et al, 2014). 
In addition, the NB-BAL is well tolerated and clinically useful in mechanically ventilated 
newborns. This prospective study shows that NB-BAL is effective in collecting distal 
respiratory tract secretions, with a minor degree of contamination. These results suggest 
that NB-BAL fluid microscopic examination and cultures can offer a sensitive and specific 
means to diagnose VAP in newborns and may provider relevant information about the 
causative pathogens. In VAP, NB-BAL was contributive to decision-making concerning 
antimicrobial therapy (Köksal et al, 2006). 
Moreover, 73 VAP events were documented throughout the study, 90.4 % (66/73) of them 
revealed positive isolates on culturing their NB-BAL (37/42, 88 % in phase-I &29/31, 93.5 
% in phase-II). Gram negative bacteria were the most commonly isolated micro-organisms 
(97.2 % versus 93.1 % in phase-I and II respectively), klebsiellapneumoniae was the 
leading causative pathogen throughout the study period. No single case of Gram-positive 
isolates was diagnosed in phase-I cases, compared to 6.9 % (2 cases) among those in 
phase-II. Fungus, namely Candida spp. was the single isolate from one case in phase-I, but 
were isolated mixed (Azab et al 2015). Non-bronchoscopicbronchoalveolar lavage (NB-
BAL) has been shown to be the most reliable sampling method for diagnosing VAP 
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reported the sensitivity, specificity, and positive and negative predictive values of NB-
BAL fluid culture for VAP diagnosis in 145 newborns as 90%, 90%, 70%, and 97%, 
respectively (Morrow et al, 2013). 
2.2 Epidemiological background 
In Lebanon the VAP incidence was 47%, in Jordan it was 25.2% and in Egypt it was 
55,3%, in newborn (Khttab et al, 2014). National Nosocomial Infection Surveillance 
(NNIS) program has published an important data about VAP, saying that VAP is second 
most frequent cause of nosocomial infection (20%) in pediatric intensive care unit, with 
ratesVAPin oscillate from 1,4 to7 episodes per 1000 ventilator days. In developing 
countries the range is significantly higher, it rates from 16,1 to 89 episodes per 1000 
ventilator days. Shedding light on neonatal population, the incidence is influence by the 
gestational age and regional economic development. The developed countries have the 
incidence which ranges between 2,7 to 10,9 episodes per 1000 ventilator days on the other 
hand this incidence in the developing countries may reach up to 57,2  cases per 1000 
ventilator days the previous difference between the ranges can be illustrated by using 
different criteria to define VAP (Cernada et al, 2014). 
According to the data reported in healthcare associated infection (HAIs) VAP is common 
in NICU and proportions between 6,8% and 57%. The range of VAP incidence in an 
Iranian and Turkish NICU were (3,8/ 1000) and (11,6/1000) ventilator days, respectively. 
A higher incidence was reported in anther Iranian stay 42% of 38% neonates on 
mechanical ventilation. According to a lot of studies from USA, Italy and Iran the VAP 
prolonged mechanical ventilation by almost 8-12 days. Increasing the length of stay was 
the main cause of reaching the attributable coasts up 1040 US$ in Iran and 51,157 US$ in 
the USA (Aelami et al, 2014).  
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2.3 Definition of VAP 
VAP in the neonate is a condition characterized by one or more of the following signs; 
Worsening of gas exchange [e.g. oxygen desaturations (e.g. pulse oximetry<94%), 
increased oxygen requirements, or increased ventilation demand] (Cernada et al, 2014). At 
least four of the following signs as considered as symptoms to diagnose VAP:1- fever (>38 
c˚), hypothermia (<36,5c˚), or temperature instability 2- new onset or increasing 
bradycardia (<80/min) or tachycardia (>200/min) 3- new onset or increasing tachypnea (> 
60/min) or apnea (> 20 seconds)  4- new onset or increasing signs of dyspnoea (retraction, 
nasal flaring, grunting) 5- increasing production of respiratory secretion and need for 
suctioning 6- purulent tracheal secretion 7- isolation of a pathogen in respiratory secretions 
8- elevated c-reactive protein (>20 mg/l) (Aelami et al, 2014). 
2.4 VAP diagnosis problem 
Reviewing literaturesshows that thereare no golden standards to diagnose VAP, especially 
among neonates. Some studies diagnosed VAP by depending on radiological criteria only 
(chest infiltration), other studies diagnosed it by depending on microbiological criteria only 
(BAL positive culture), another criteria used to diagnosed VAP was clinical criteria only 
(at least 3 from 7 pointes found), these clinical signs are leukocytosis or leukopenia, 
hyperthermia or hypothermia, tachypnea or dyspnea, tachycardia or bradycardia, abnormal 
of PH stability, apnea and increasing production of respiratory secretion.In some other 
studied.The researches mixed between clinical and radiological criterion or between 
radiological and microbiological criterion. In this study, the researcher depends on positive 
diagnoseson chest x-ray, chest infiltration and positive culture of BAL. In the clinical 
criteria positive clinical finding should be at least 3 from 7 clinical signs, these clinical 
signs are: leukocytosis or leukopenia, hyperthermia or hypothermia, tachypnea or dyspnea, 
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tachycardia or bradycardia, abnormal of PH stability, apnea and increasing production of 
respiratory secretion.  
2.5Classification of neonatal VAP 
2.5.1 Early onset VAP 
It is defined as pneumonia that occurs within 4 days after 48 hours and this is usually 
attributed to antibiotic sensitive pathogens whereas (Kalanuria et al, 2014).  
2.5.2 Late onset VAP 
Late onset VAP is more likely caused by multidrug resistant (MDR) bacteria and emerges 
after 4 days of intubation (Kalanuria et al, 2014). 
2.6 Clinical signs of VAP 
Neonates are examined after birth to check for any abnormalities and to make sure the 
transition to extra uterine life. In addition, they should go througha complete physical 
examination within 24 hours of birth. The most common signs an associated with neonatal 
VAP includes: 
2.6.1 Bradycardia 
In the healthy preterm, the average heart rate ranges from 120 to 170 beats/min less than is 
considered bradycardia and in the other hand in the healthy infant between (0-3 months), 
the average heart rate ranges from 100 to 150 beats/min less than is considered bradycardia 
(Kliegman et al, 2015). 
2.6.2 Tachycardia 
In the healthy preterm, the average heart rate ranges from 120 to 170 beats/min and more 
than 170 beats is considered tachycardia in preterm and in the other hand in the healthy 
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infant between (0-3 months), the average heart rate ranges from 100 to 150 beats/min and 
more than 150 beats is considered tachycardia in neonates full term (Kliegman et al, 2015). 
2.6.3 Temperature 
The normal range of body temperatures for neonate 36.5c˚ to 37.5c˚ but hypothermia for 
neonates is divided to three categories as: Hypothermia in whichthe range of body 
temperature less than < 36.5c˚, Sever hypothermia in which the range of body temperature 
less than < 32.0c˚ and finally Hyperthermia the normal range of body temperatures for 
neonate 36.5c˚ to 37.5c˚ but hyperthermia for neonates is more than or exceeds to > 37.5c˚ 
(Short et al, 2015). 
2.6.4 Tachypnea 
The normal range of respiratory rate for neonate preterm 40-70 breath/min and infant (0-
3months) 35-55 breath/min. Tachypnea alone means an increased respiratory rate 70 
breath/min to preterm and increased respiratory rate 55 breath/min to full term (Kliegman 
et al, 2015). 
2.6.5 Apnea 
Apnea is defined as the cessation of pulmonary airflow for a specific time interval, usually 
longer than 10 to 20 seconds. Bradycardia often accompanies prolonged apnea (Marcdante 
et al, 2011).   
2.7 Indication for neonate to be connected to MV: 
2.7.1 Congenital Anomalies 
 Are also known as birth defects, congenital disorders or congenital malformations. 
Congenital anomalies can be defined as structural or functional anomalies (e.g. metabolic 
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disorders) that occur during intrauterine life and can be identified prenatally, at birth or 
later in life (WHO, 2015). 
2.7.2 Meconium aspiration syndrome 
Meconium aspiration syndrome (MAS) is among the most common causes of hypoxemic 
respiratory failure in term newborns who require intensive care. Recent studies estimate 
that the incidence of MAS in babies greater than 37 weeks’ gestation ranges from 0.4% to 
1.8%. Among babies born after 39 weeks’ gestation with lung disease requiring 
mechanical ventilation, more than half suffer from MAS (Gleason et al, 2012). 
Meconium aspiration syndrome (MAS) or other aspiration syndromes (blood or amniotic 
fluid) rarely present in the LBW newborn. These diagnoses are characteristically seen in 
the full term or post-date newborn. Meconuim stained amniotic fluid in the LBW 
premature infant should arise serious suspicion for neonatal infection, particularly neonatal 
listeria, newborns with MAS develop substantial respiratory disease with cyanosis, 
hypotension, acidosis, and coarse ronchi on physical examination. Persistent pulmonary 
hypertension of the newborn (PPHN) as a secondary diagnosis to MAS or other aspiration 
syndromes should be suspected in all near-term newborns with significant distress and 
passage of meconium. The chest X- ray of MAS classically demonstrates hyper infiltration, 
air trapping, patchy infiltrates, and possibility of air leaks (Guha et al, 2005).  
2.7.3 Birth asphyxia 
The definition of birth asphyxia is the failure to establish breathing at birth which results in 
approximately 900,000 deaths per year, where it's considered as one of the major causes of 
early neonate mortality. WHO and the American Academy of Pediatric have recommended 
guidelines for neonatal resuscitation contain a set of typical practice that enhances the 
outcomes in asphyxiated neonates. This set of slandered practice sheds the light on the 
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importance of drying, stimulating, warming, newborns in distress, in addition to its role in 
suctioning the airways. In the case of appearing some clinical signs such as apnea or 
bradycardia on the face of a baby, the ventilation with the use of bag and mask or 
equivalent device should be applied. This step was considered as a critical to manage 
asphyxiated newborns. By the timely application of these techniques a lot of babies have 
acquired a noticeable capability to resist hypoxia and have improved quickly. On the other 
hand few newborns have required chest compression or medication administration (WHO, 
2008). 
In spite of that there is no doubt that, both in industrialized and low income countries a 
large number of newborn infants are in need of resuscitation at birth. Therefore and 
because a vast number of deliveries throughout the world still occur at home without 
authorized health personnel present, it is also important to develop simple resuscitation 
routines mask. However, only a few newborn infants need advanced resuscitation. In 1:100 
to 1:700 endotracheal intubation is needed, 1:1000 needs chest compression, 6:10,000 need 
epinephrine (adrenaline) and as few as 1:12,000 of near-term and term infants need volume 
therapy [6–8]. For preterm infants these numbers are higher (Buonocore et al, 2012). 
2.7.4 Respiratory distress syndrome 
Respiratory distress syndrome (RDS) [also called hyaline membrane disease (HMD)] is a 
respiratory disease that primarily affects preterm infants; its incidence is inversely related 
to gestational age and birth weight. It occurs in about 15-30% of those between 32-36 
weeks' gestation, in about 5% beyond 37 weeks' gestation (MOH, 2010). 
Respiratory difficulties are encountered in 5 to 7 percent of newborn babies, while 
pulmonary pathology is the most frequent autopsy finding in the neonates. The clinical 
diagnosis of respiratory distress is suspected when the respiratory rate is more than 60 per 
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minute in a quiet resting baby, and there are either inspiratory costal recessions or 
expiratory grunt. During first 72 hours, infant with RDS have increasing distress and 
hypoxemia. In infants with sever RDS; the development of edema, apnea, and respiratory 
failure necessitates assisted ventilation (Parthasarathy et al, 2009). 
2.7.5 Sepsis 
There are two distinct times in the newborn period when sepsis is more likely. These are 
described as early onset and late onset infection: 
2.7.5.1 Early onset infection 
Ii is defined as symptoms that appear at birth or within the first 48 hours following birth. 
This may have occurred in utero due to organisms from the mother so that the baby is born 
with a congenital infection that may be severe if not immediately treated. Most cases of 
early onset infection are caused by group B streptococcus (GBS) and infants present with 
symptoms either immediately or within the first few hours (Edwards et al 2010). 
The signs of early-onset infection may be subtle, with tachypnea suggesting “wet lung 
disease” or may be more overt with grunting, flaring, and subcostal and intercostal 
retractions. Because the signs of sepsis can be relatively nonspecific, such as poor feeding 
and increased sleepiness, they can be overlooked. In newborn or intermediate or intensive 
care nurseries, one must be attuned to subtle abnormal findings in newborn infants. The 
clinical signs of neonatal sepsis include hyperthermia or hypothermia, respiratory distress, 
apnea, cyanosis, jaundice, hepatomegaly, abdominal distention, feeding abnormalities, and 
neurologic abnormalities. Autopsy findings in preterm infants with fatal early-onset GBS 
infection suggested that surfactant deficiency respiratory distress syndrome was common 
(Gleason et al, 2012).  
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2.7.5.2 Late onset infection 
Is define as those infections that arise after the initial 48-hour period. Again, it is possible 
that these organisms originated from the mother but it is more likely that they came from 
the environment. The most commonly responsible organism is coagulase negative 
staphylococci (CONS) (Edwards et al 2010). 
The signs presenting features of late-onset sepsis include increased apnea, feeding 
intolerance, abdominal distention, guaiac-positive stools, increased respiratory support, and 
lethargy and hypotonia Because these symptoms are nonspecific, ELBW infants are 
frequently evaluated for infection and treated with empiric antibiotic therapy (Gleason et al 
2012). 
Late-onset sepsis (LOS) affects 25 to 50% of ELBW infants and the mortality rate varies 
from 20 to 80%, depending on the causal pathogen. The main risk factors for LOS are the 
use of central lines, mechanical ventilation and parenteral nutrition. The clinical diagnosis 
of LOS is made more difficult in ELBW infants because of nonspecific clinical features 
anda lack of sensitive diagnostic tests (Buonocore et al 2012). 
2.7.6 Premature babies 
The major reason for ventilating an infant is apnea. However, the difficult decision comes 
with deciding when to ventilate an infant, who is very premature, or breathing with 
retraction of the lower chest wall, or requiring oxygen treatment, or having numerous 
apneic episodes. Intubation and ventilation of very premature babies with respiratory 
difficulty soon after birth used to be considered mandatory. However, it is now realized 
that even very premature babies can often be supported with CPAP alone particularly if 
treated early with caffeine (Buonocore et al, 2012). Premature newborns with birth weights 
of 500–1250 grams who required ventilator support between 7 and 21 days of age. Infants 
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were treated with study gas for a minimum of 24 days, and had an estimated OI of 7 
(Buonocore et al, 2012). Weights of 500–1250 grams and requiring mechanical ventilation 
in the first 48 hours of life were randomized to treatment with 5 ppm iNO or placebo gas 
and treated for 21 days or until extubated (Buonocore et al, 2012). 
2.8 Procedures and investigation that used to detect VAP: 
2.8.1 Pulse oximetry 
Noninvasive test in which using a small sensor is attach to a fingertip or toe, the sensor 
used to estimate of oxygen saturation (SaO2) in blood (National Heart Lung and Blood 
Institute, 2011). SaO2 below 88 % would indicate hypoxia. While SaO2 between 88 – 94 % 
would be normal in the more premature neonates, higher SaO2 values are normal in full 
term neonates. Increasing requirement of inspired oxygen, to maintain normal SaO2 would 
therefore be a threatening sign (Diwakar, 2003). 
It detects the O2 saturation of hemoglobin by measuring the blood absorption of two or 
more wavelengths of light. It is noninvasive, easy to use, and reliable. Because of the shape 
of the ox hemoglobin dissociation curve, O2saturation does not decrease much until the po2 
reaches approximately 60 mm Hg. Pulse oximetry may not accurately reflect true O2 
saturation when abnormal hemoglobin is present (carboxyhemoglobin, methemoglobin), 
when perfusion is poor, or if no light passes through to the photo detector (nail polish) 
(Marcdante  et al, 2011). 
2.8.2 Chest X-ray 
Theyare useful in assessing respiratory disease in children. In addition to determining lung 
abnormalities, they provide information about the bony thorax (rib or vertebral 
abnormalities), the heart (cardioaortic arch/vascular rings, rib notching). Chest radiographs 
should be obtained in both the posteroanterior (PA) and lateral projections. Estimation of 
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lung hyperinflation based on a single PA view is unreliable, whereas flattened diaphragms 
and an increased AP diameter on a lateral projection indicates hyperinflation. Expiratory 
views and fluoroscopy may detect partial bronchial obstruction due to an aspirated foreign 
body resulting in regional hyperinflation because the lobe does not deflate on exhalation. 
Routine chest radiographs should be obtained after a full inspiration (Marcdante et al, 
2011). In this study, the researcher based on positive radiological diagnoses; chest x-ray to 
detect the existence of chest infiltration. 
2.8.3 Arterial blood gas test (ABG) 
Blood gas analysis provides information about the effectiveness of both oxygenation and 
ventilation. However, arterial samples are more difficult to obtain, so capillary and venous 
blood samples are more commonly used. The PCO2 from a capillary sample is similar to 
that from arterial blood. The PCO2 in venous samples is approximately 6 mm Hg higher 
than arterial PCO2. The ratio of the serum bicarbonate concentration to PCO2 determines 
the PH. Capillary or venous samples should not be used to assess oxygenation (Marcdante 
et al, 2011). Arterial blood gas allows measurement of CO2 levels and analysis of the 
severity of oxygenation defect through calculation of an alveolar-arterial oxygen 
difference. A normal PCO2 in a patient who hyperventilation should heighten concern 
about the risk of further deterioration (Marcdanteet al, 2011). 
2.8.4 Minibronchoalveolar lavage 
Minibronchoalveolar lavage (mini-BAL) is a nonbronchoscopic bedside method of 
performing a small-volume BAL for quantitative culture results to guide antibiotic therapy 
prescribed for patients suspected of VAP. These catheters are smaller in diameter than 
abronchoscope, so the risk of complications is minimized. The procedure typically only 
requires the sampling catheter to be in the airway for 1 to 2 minutes. Moreover, lavage 
 
 
27 
 
volumes are significantly smaller than those used in bronchoscopy, so there is less residual 
fluid in the lung, resulting in faster post procedure patient recovery time (Hess et al, 2016). 
BAL and min-BAL are considered to be invasive despite their blind performance. They 
require the insertion of a catheter and available amount of fluid into the lung (Torres et al, 
2006). 
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Chapter (3) Methodology 
3. Methodology 
This chapter presents the methodology of the study implemented to answer the research 
questions. Different items were explained: study design, place of the study, study 
population, sample size, sampling process, period of the study, inclusion and exclusion 
criteria, validity, ethical and administrative consideration, study tools, pilot study, data 
collection, data management, and limitation of the study. 
3.1 Study design 
The design of this study is descriptive, analytical, cross sectional study as it assesses 
incidence and determinants of VAP of neonates at Governmental hospitals in GG. Cross-
sectional study is appropriate for describing the status of phenomena or for describing 
relationships among phenomena at a fixed point in time (Polit& Beck, 2004). 
3.2 Setting of study 
This study was carried out at GG, mainly at NICU in AL- Shifa Hospital from Gaza 
governorate, AL-Tahreer Hospital from the Khan Younis Governorate, Al-Naser pediatric 
Hospital from GG and finally European Gaza Hospital from both Rafah and Khan Younis 
governorates. 
3.3 Study population 
The target population of the survey consist all the neonates who are admitted to NICU 
department and connected to the MV for more than 48h, they are approximately estimated 
102 baby. 
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3.4 Sampling process and sample size 
After reviewing the annual reports of MOH, there were no reports show the exact number 
of the babies who are connected to MV in NICU. So the researcher followed the ventilated 
babies more than 48 hours in the four hospitals. Accordingly, there were 13 babies in AL- 
Shifa Hospital during 2 Weeks, three babies in Al-Naser pediatric hospital also during two 
weeks, only one baby in AL-Tahreer Hospital and four babies in European Gaza hospital. 
The study survey consisted of 102 newborn babies. The number of cases admitted during 
this period were 102 babies admitted to neonatal intensive care unit at Al-Naser pediatric 
Hospital, AL- ShifaHospital, AL-Tahreer Hospital and finally European Gaza Hospital 
during 100 days (period of data collection) and diagnosed with VAP.  
3.5 Period of the study 
The study wasinitiated immediately after the approval of the proposal. A pilot study was 
conducted in the first ten days of May 2016. Data collection started in thefirstof May 2016 
and continued to the tenth of August 2016, approximately 100 days. Data entry, analysis 
and writing the final report continued till the middle of March 2017. 
3.6 Eligibility criteria 
Sample of this study was chosen according to the following criteria. 
3.6.1 Inclusion criteria for cases 
 Age less than 28 days. 
 Admitting to the NICU at Governmental Hospital. 
 Being diagnosed as VAP confirmed by physician. 
 One Chest x ray infiltration. 
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 Neonates infected by VAP because they have been connected to mechanical 
ventilator for more than 48 hours.  
3.6.2 Exclusion Criteria: 
 Babies older than 28 days. 
 Neonates diagnosed by pneumonia before 48 hours from connecting to mechanical 
ventilator.  
 Neonates who diagnosed with congenital pneumonia. 
3.7 Tools of the study 
Data were collected by the researcher using constructed direct observation checklist sheet 
(annex 8) to observe the neonates directly in NICU on mechanical ventilators and to record 
the clinical manifestation, microbiological results, radiological chest x-rays, the 
measurement of birth weight, gestational age, length of intubation period, Re-intubation, 
and invasive devises such as umbilical line, chest tube, transfusion of blood and blood 
products and Ryle tube in the checklist sheet.  In addition, the researcher will ask the 
physician about the infiltration of chest x-ray as well as he recorded the vital signs of the 
neonate from his medical record file.  
3.7.1 Observational checklist sheet 
The first direct observation checklist sheet constructed and structured by the 
researcher after reading the related literature. It includes the following section:  
 The first part includes neonatal information about gender, address,hospital name 
and date of admission.  
 The second part includes gestational age, birth weight and type of delivery. 
 The third part includes intubation profile  about length of intubation and times of 
ETT changed  
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 The fourth part includes BAL culture results and the name of causative 
microorganism. 
 The fifth part includes invasive devises profile:  umbilical line, Ryle feeding, chest 
tube, and administration of blood products. 
 The sixth part handles the chest x-ray including chest x-rays before and after 
intubation and examines any chest infiltration on x-rays.   
 The seventh part handles the clinical sings of neonates including: heart rate, body 
temperature, respiratory rate as well as if neonates enter apnea or not. 
 The eighth part deal with the medical diagnosis of neonates including: respiratory 
distress, birth asphyxia, sepsis, premature, congenital anomalies or others 
diagnosis. 
 The ninth part is the laboratory test of CBC, ABG and blood culture result.      
Thechecklist sheet was reviewed by seven experts(annex 9). The aim of thisstep is to 
increase both content and criterion validity. 
The second direct observation checklist sheet (annex10), constructed and structured by 
the researcher after reading the related literature. It includes the following: 
 The first part investigates hand washing including hand washing before 
suction,hand washing after suction, hand washing during several contacts for the 
same patient and hand washing according WHO. 
 The second part includes disinfectant tools of ETT including:ETT disinfectant, 
M.V disinfectant,laryngoscope disinfectant andAmbo Bag Mask disinfectant. 
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 The third part includesinfection control procedures for the Suction process 
including: wearing sterilizedgloves,changing suction connection,using suitable 
suction gauge, and reusing suction tube and etc. 
 The fourth part includes infection control policieswhich containpolicy written by 
UVC,protected VAP policy, VAP isolating,VAPstatistics and receiving training or 
lectures. 
 The fifth part is about infection control Kitsexamining the availability of liquid 
soap, sterilization soap, Alcohol, Hand rubbing andthe toilet tissues. 
3.8 Validity of the instruments 
Validity tries to assess whether a measure of a concept really measures that concept, that 
is, the extent to which the concept measures the thing it was designed to measure (Singh, 
2007). 
The researcher appliedtwo types of validity as follow: 
1. Face validity: the checklist used for data collection in the study which wasprepared by 
the researcher to ensure high face validity. 
2. Content validity  
After reviewing many studied related to the subject, the researcher designed the study 
checklist for the purpose of the study. The validity of checklist has been examined by 
sending the constructed checklist with the enclose covering letter about the objectives of 
the study to seven experts working in the different health field in order to give their points 
of views on the checklist. The checklist was modified according to their suggestions and 
advices.Standardization of the procedures of the measurement also will be done as follows:  
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3.8.1 Standardization of Performing Mini-BAL ( Hooser, 2006). 
Step By Step Procedure for Performing Mini-BAL 
1. Obtain, from patient and staff, information regarding the pneumonia (location, etc.) 
and any other pertinent patient information (e.g. physical abnormalities). 
2. Gather and prepare necessary equipment prior to performing the procedure: 
 BAL catheter 
 Premarked laboratory specimen slip 
 Specimen trap 
 Sterile saline 
 Drape 
 SpO2 monitor 
3. Increase the FIO2to 1.00 (i.e., 100% oxygen). 
4. Closely monitor patient throughout procedure for evidence of desaturation. If 
desaturation occurs (SpO2< 90%), the procedure should be terminated immediately. 
5. Wash and dry hands appropriately. 
6. Open BAL catheter package in a sterile manner and lay on sterile field. 
7. Put on sterile gloves and mask. 
8. Connect 30 ml syringe with 1-3 ml sterile saline. 
9. Pass catheter through access port elbow extending to 1½ inches. Attach access port 
elbow between the Endotracheal Tube and ventilator circuit. Once the adapter is 
secured into the ET tube, extend the BAL catheter to the end of the ET tube. Align the 
numbers on the ET tube with the numbers on the BAL catheter to show when this has 
been achieved. 
10. Extend the BAL catheter 2-4 cm (depending on the ET tube position and patient size) 
beyond the end of the ET tube and flush the catheter with 1-3 ml sterile saline. 
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11. Direct the catheter tip to the chosen lung by orienting the O2 port to the side of the 
chosen lung. 
12. Advance the catheter until about 1-3 cm of BAL catheter protrudes beyond the access 
port elbow, and then advance the inner catheter from the outer catheter until resistance 
is met. The inner catheter should now be in a wedge position. 
13. Lock the catheter in place. Note: For patients with untrimmed Endotracheal Tubes, the 
catheter should protrude no more than 6 cm from the patient’s mouth or nose. 
14. Attach a 30 ml syringe to the BAL catheter stop-cock and instill 1-3 ml of saline. 
15. Aspirate the sample into a specimen trap by reversing stop-cock and setting the wall 
vacuum regulator to 40-60 mm Hg or pull the sample back into the syringe according 
to hospital protocol. 
16. Repeat until the total volume of BAL fluid has been infused and an adequate 
17. Disconnect the specimen trap, unlock the catheter and retract the inner catheter. Then 
remove the BAL catheter and elbow access adapter from the Endotracheal Tube and 
ventilator circuit. Reconnect the ventilator tubing to the ET tube. 
18. Attach the appropriate patient label and lab slip marked “BAL fluid”. 
19. Send the specimen to the lab for quantitative analysis. 
3.9 Reliability of instrument 
Reliability signifies the issue of consistency of measures, that is, the ability of a 
measurement instrument to measure the same thing each time it is used (Singh, 2007).  
The following steps will be done to assure instruments reliability: 
 Standardization of the method of data collection was guaranteed. 
 Then, the data entry in the same day of data collection would allow possible 
interventions to check the data quality or to re-fill the checklist when required. 
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 Re-entry of 5% of the data after finishing data entry will assure correct entry 
procedure and decrease entry errors. 
3.10 Data entry and analysis 
The researcher used the Statistical Package of Social Science (SPSS virgin. 20) program 
for data entry and analysisin addition to Microsoft excel. The steps of analysing the 
collected data were as the following:  
 Reviewing the filled checklist. 
 Coding the checklist. 
 Recording on categories.  
 Defining and coding the variable. 
 CleaningData.  
 Frequency tables of all variables.  
 Cross tabulation of the results.  
 95% CI are the statistical tools of measurement use to check the statistical 
relationship between the determinants  (independent variables) and the occurrence 
of VAP (dependent variable) and to assess the statistical significant of difference.  
To achieve the goal of the study, the researcher used the (SPSS version 20) for analyzing 
the data.Measurements of central tendency including mean, mode, median, and standard 
deviation were used to determine the frequency of certain determinates in neonates. Other 
tests such as chi-square were used to examine the relationship between certain determinate 
such as re-intubation, length period of intubation and others with the occurrence of VAP 
among neonates in GG. 
 
 
36 
 
3.11 Pilot study 
A piloting process was conducted before starting data collection. The piloting process aims 
to test the clarity and applicability of the tool used, also to estimate the length of time 
required for data collection as well as to clearly detect any barriers that might hinder the 
study. Itwas conducted on 16 cases, 3 cases from every hospital were selected by the 
researcher, the cases chosen from the first ten babies admitted to NICU with VAP. 
3.12 Ethical and Administrative consideration 
 An official letter of request wasobtained from MOH to conduct the study in the 
governmental hospital (Annex 4.1 and 4.2).  
 An official letter of approval to conduct the study was obtained from the Helsinki 
committee (Annex 6). 
3.13 limitation of the study 
 Frequent electricity cuts off affected the ability to accomplish the work in a timely 
manner. 
 Financial constraints, the study was self-funded therefore the researcher faced 
financial constraints. 
 Scarcity of literatures and access to published articles.  
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Chapter (4) Results and Discussion 
In this chapter, the researcher illustrates the main results of the study in a comparative way 
between positive VAP cases and negative VAP cases that were connected to mechanical 
ventilated more than 48 hours. Primarily,it demonstrates the descriptive variations between 
positive cases and negative cases. Moreover, it illustrates the different determinants 
including intubation profile, neonatal profile, and sensitivity of BAL and invasive 
devisesthat associated with neonatal VAP. Furthermore, this chapter answers the study 
questions by using different statistical tests including descriptive statistics such as 
frequency distribution for study variables, means and percentages, in addition to different 
inferential statistics that investigate the relationships between variables. M.V neonates in 
the study was observational checklist to collect clinical signs, radiological changes and 
microbiological sensitivity related to VAP diagnosis, variables of intubation profile, 
neonatal profile, sensitivity of BAL and invasive devises. 
The findings of this study were explained compared with other global and regional studies 
in attempt to interpret the results and its implication. The results could help in developing 
preventive health education and health promotion programs. 
4.1 characteristics of ventilated neonate survey in NICU 
Characteristics of the study of ventilated neonate are shown in (Table 4.1). It surveys 102 
cases of ventilator neonates during 100 days in the four of NICU in Gaza governorates. 
The table shows the characteristics of ventilated neonates for more than 48 hours. The 
study survey consisted of 102 babies, divided into four groups; the first group consisted of 
46 babies admitted to neonatal intensive care unit (NICU) at Al-Shifa Hospital in Gaza 
governorate and neonates were put on mechanical ventilators for more than 48 hour; the 
second group consisted of 25 cases who also admitted to neonatal intensive care unit 
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(NICU) at AL-Tahreer Hospital in Khan Younis governorate; the third group  consisted of 
21 cases at Al-Nasser Pediatric Hospital in Gaza governorate who also admitted to 
neonatal intensive care unit (NICU) and put on mechanical ventilator for more than 48 
hour; the fourth group consisted of 9 cases at European Gaza Hospital in Rafah 
governorate who also admitted to neonatal intensive care unit (NICU) and put on 
mechanical ventilator for more than 48 hour. The study showssignificant variations in 
characteristics of ventilated neonate survey included (gender, address, and hospital name).  
Table 4.1 Distribution of neonates according to gender, address and hospital name 
Variable 
 
Total 
 
End VAP diagnosis 
χ2 
P-
Value 
Negative 
VAP 
Positive 
VAP 
No. % No % No % 
Gender 
Male 51 50.0 27 45.8 24 55.8 
1.005 0.316 
Female 51 50.0 32 54.2 19 44.2 
Address 
Gaza city 40 39.2 25 42.4 15 34.9 
4.869 0.301 
North Gaza 17 16.7 10 16.9 7 16.3 
Middle zone 14 13.7 9 15.3 5 11.6 
Khanyounis 23 22.5 9 15.3 14 32.6 
Rafah 8 7.8 6 10.2 2 4.7 
Hospital 
Name 
Al-Shifa 
Hospital 
47 46.1 29 49.2 18 41.9 
8.878 0.031 
AL-
TahreerHospit
al 
25 24.5 9 15.3 16 37.2 
Al-Naser 
Hospital 
21 20.6 13 22.0 8 18.6 
European 
Gaza Hospital 
9 8.8 8 13.6 1 2.3 
 
Table 4.1 shows that the number of male cases equals the number of female cases. 50.0% 
for male and 50.0%. 55.8% of male cases where diagnosed with positive VAP and 44.2% 
female positive cases. The results show that there is no relationship between gender and 
incidence of VAP [χ2=1.005, P-value = 0.316]. This study is supported by some studies 
such as (Badr et al, 2011).There were nosignificant differences regarding gender 
 
 
39 
 
orindication of NICU admission. This result disagrees with other study by (Srinivasan et 
al, 2009). Female gender and postsurgical diagnosis were associated with an increased risk 
of developing ventilator-associated pneumonia in these patients. 
The positive cases in AL- shifa hospital, AL-TahreerHospital, Al-Naser Hospitaland 
European Gaza Hospitalwere (41.9%, 37.2%, 18.6%, and 2.3) respectively. Most cases 
were in Al-Shifa Hospitalthen AL-Tahreerhospital(41.9% and 37.2%) respectively.  
 
Figure 4.1: Distribution of cases according to governorates 
Figures 4.1 shows the survey regarding demographic distribution, the table clarify cases 
diagnosed VAP by governorates. 34.9% of cases live Gaza City, 32.6% in Khanyounis 
governorate, 16.3% in North Gaza,11.6% in Middle zone and approximately 4.7% of them 
live in Rafah. 
The researcher thinks that the high precentage in Gaza city is due to the high density of 
population, as well as the percentage in khanyounis was quiet high because of the same 
reason.On the other hand, the percentage in Rafah formulates the lowest because of the low 
density of population. 
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Figure 4.2: Distribution of cases according to hospital 
Figures 4.2 shows the survey according to the hospitals that provides MV for neonates in 
Gaza governorates as the following; 41.9% in Al-Shifa Hospital, 37.2% in Al-
TahreerHospital, 18.6% in Al-Naser Hospital, 2.3% in European Gaza Hospital. The test 
showed strong relationship between hospital perfusion and incidence of VAP [χ2=8.878, 
P-value = 0.031]. The researcher illustrates the reasons behind the previous distribution of 
VAP incidence. 
First, in Al-Shifa Hospital the percentage of VAP reached to 41.9% which was the highest 
percentage because it is the major main hospital of Gaza city and the North of Gaza, it 
receives very large number of risky cases such as premature babies and deliveries, it also 
receives neonates from obstetrics and gynecology department and it also suffers from the 
shortage of medical team although they are well qualified. 
Second, in AL-Tahreerhospital, the percentage of VAP reaches to 37, 2% which was a little 
bit lower than Al-Shifa hospital because it represents the main hospital of Rafah city and 
KhanYounis city.It also receives neonates from obstetricsand gynecology department; the 
hospital also suffers from the weakness of infection control supervision. 
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Third, in Al-Naser Hospital, the percentage of VAP reaches to 18,6 %. The reasons behind 
this percentage are: the strong infection control supervision, the appropriate number of 
qualified medical staff and receiving neonates who seek medical help afterbeing 
discharged from obstetrics and gynecology department.  
Fourth, in European Gaza Hospital the percentage of VAP reached to 2,3% because of  the 
qualified medical team and  the low number of ventilated babies.    
Table 4.2Distribution of neonates according gestational age, and birth weight 
Variable 
 
Total 
 
End VAP diagnosis 
χ2 
P-
Value 
Negative 
VAP 
Positive 
VAP 
No. % No % No % 
Birth weigh 
Very low birth 
weight  
33 32.4 15 25.4 18 41.9 
3.330 0.189 Low birth weight 33 32.4 20 33.9 13 30.2 
Normal birth 
weight 
36 35.3 24 40.7 12 27.9 
Mean of birth weight  
2164.4706 
Median 2002.000 Mode 1200.00 SD 893.68196 
Gestational 
Age 
Preterm 64 62.7 35 59.3 29 67.4 
1.890 0.389 Full term 38 37.3 24 40.7 14 32.6 
post term 3 2.9 1 1.7 2 4.7 
Mean of gestational age  34.47 Median 35.0000 Mode 38.00 SD 3.88 
Ryle tube 
Percent 41 69.5 41 95.3 
10.551 0.001 
Absent 18 30.5 2 4.7 
 
Table 4.2 shows the survey concerning birth weight was classified into three categories: 
very low birth weight"between 1000-1499g", low birth weight "between 1500-2499g 
weeks",and normal birth weight "between 2500-4000g weeks". The incidence of positive 
VAP in VLBW weight is 41.9% while the incidence of the low birth weight is 30.2% and 
the incidence of the normal birth weight is 27.9%. The test shows that there is no 
relationship between birth weight and incidence of VAP in this study [χ2=3.330, P-value = 
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0.189].Although the test in this study and P-value is more than 0.05 and not statistically 
significant, but the researcher found that there is a difference between birth weight and 
normal birth weight percentages. 
This result support the study of  (Foglia et al., 2007) whichfocus on estimated gestational 
age (EGA) rather than birth weight in their 10-month-long case control study of 211 
intubated NICU patients. VAP rates were much higher in babies with an EGA of <28 
weeks (19 VAP cases) than in babies with an EGA of ≥28 weeks (5 VAP cases) (P < 
0.001). The VAP rate per 1,000 ventilator days was also higher in babies with an EGA of 
<28 weeks (6.5/1,000 ventilator days) than in babies with an EGA of ≥28 weeks (4.0/1,000 
ventilator days) but was not statistically significant (P = 0.34). Not all investigators found 
an inverse relationship between birth weight and frequency of VAP. This result disagrees 
with other study by (Apisarnthanarak et al., 2003) which VAP occurred at high rates in 
extremely preterm neonates and was associated with increased mortality. Additional 
studies are needed to develop interventions methods in order to prevent VAP in NICU 
patients.  
Concerning the gestational age, the survey isclassified into three categories: premature 
"less than 37 weeks", full terms "between 37- 40 weeks", and post term "more than 41 
weeks".The incidence of positiveVAP of the premature is 67.4% while the incidence of the 
full terms is 32.6% and the incidence of the post term is4.7%. The test shows no 
connection between governorates and incidence of VAP [χ2=1.890, P-value = 0.389]. 
Although the test in this study and P-value is more than 0.05 and is not statistically 
significant but the researcher found that there is a difference between premature and full 
terms percentages; the incidence of VAP in the premature is approximately 67.4% while 
the incidence in the full terms is approximately 34.36% and finally post term is 
approximately 2.9. The researcher justifies these results due to the survey contents in 
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which the percentages of premature who are less than 37 weeks were62.7% and the 
percentage of full term was 36.3%. 
For the insertion of Ryle tube and incidence of VAP, the percentage of present insertion 
Ryle tube shows 95.3% of neonates, whereas when the absence of Ryle tube insertion, the 
percentage is 4.7% of positive VAP. The test showed strong relationship between present 
insertion of Ryle feeding and incidence of VAP [χ2= 10.551, P-value = 0.001]. That means 
increasing the insertion of Ryle tubecan increase the incidence of the VAP among neonates. 
This result supported by a study conducted by (Wani et al., 2015) in which he clarifies that 
the use of nasogastric tube was statistically a significant risk factor associated with VAP. 
This result disagrees with another study by (Alalem et al., 2015) in which they clarify that 
there is no significant difference between VAP and non-VAP patients regarding 
continuous enteral feeding. 
Table 4.3Distribution of casesaccording to the duration of intubation&the times of 
ETT changes 
Variables 
Type of Participant 
χ2 
P- 
Value 
Negative VAP Positive VAP 
No % No % 
Length 
Period of 
Intubation 
Between 
(48-72) hours 
6 10.2 0 0.0 
21.020 
 
0.000 
 
Between 
(72_120) 
hours 
25 42.4 4 9.3 
More than 
120 hours 
28 47.5% 39 90.7 
Many times 
of ETT 
changes 
Less than 10 
times ETT 
changes 
45 76.3% 23 53.5% 
6.847 0.033 
Between (11-
20) times 
ETT changes 
9 15.3% 16 37.2% 
Over than 21 
times ETT 
changes 
5 8.5% 4 9.3% 
Mean of times of ETT 
changes 4.78 
Median 3.0000 Mode 3.00 SD 4.58 
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Table 4.3 shows the results concerning the duration of intubation which is divided into three 
categories: the first category "between 48-72 hours", the second category "between 72- 120 
hours" and finally the third category "more than 120 hours". The incidence of positive 
VAP "between 48-72 hours" is 0.0% while the incidence of positive VAP "between 72- 
120 hours" is 9.3% whereas the incidence of positive VAP "more than 120 hours"is 90.7%.  
That means the most of positive VAP occurs in the late onset of VAP and this type is 
considered dangerous because it is multidrug resistance. The test showsa strong 
relationship between the duration of intubation and the incidence of positive VAP [χ2= 
21.020, P-value = 0.000]. Increasing the length period of intubation to more than 120 hours 
increases the incidence of VAP. This result was consistent with the results of a study 
conducted by (Cernada et al, 2014).This shows that VAP increases respiratory morbidity 
and overall mortality and prolongs the hospital length of stay. VAP is especially associated 
with prematurity, low birth weight, chronic lung disease, and prolonged MV. Moreover, 
another published study in (Yuan et al., 2007) shows that neonates of VAP occurs at 
significant rates among mechanically ventilated NICU patients and is associated with care 
procedures. The risk factors of neonatal VAP were re-intubation and prolonged duration of 
mechanical ventilation 
Table 4.4Distribution of casesaccording to invasive devices 
 
Variable 
Negative 
VAP 
Positive 
VAP χ2 
P- 
Value No % No % 
Chest tube 
Present 5 8.5 25 58.1 
29.551 0.000 
Absent 54 91.5 18 41.9 
Umbilical line 
vein 
Present 12 20.3 39 90.7 
49.251 0.000 
Absent 47 79.7 4 9.3 
urinary catheter 
Present 5 8.5 22 51.2 
23.287 0.000 
Absent 54 91.5 21 48.8 
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Table 4.4 shows the results regarding invasive devises management, the table of neonates 
shows that diagnose positive VAP to percent insertion chest tube that shows 58.1% of 
neonates while were absent insert chest tube, 41.9% of positive VAP, The test showed 
strong relationship between percent insert chest tube and incidence of VAP [χ2= 29.551, P-
value = 0.000].The table shows that insertion chest tube is determinates of VAP among 
neonates. 
On the other hand, positive VAP in the presence of insertion ofULVfor neonates shows 
that the percent is 90.7% while the percent in the  absence ofULV  is 9.3% of positive 
VAP, The test showed strong relationship between insertingULV and incidence of VAP 
[χ2= 49.251, P-value = 0.000]. In this study, the researcher found that insertion ofULV is a 
determinant of VAP among neonates. This result is supportedbyanother study by 
(Petdachai, 2004). In the previous study,the result of significant clinical parameters such as 
ULV was positive [adjusted odds ratio (AOR)=2.5; 95% confidence interval (CI)=1.3 to 
4.7; p=0.007].  
According to the insertion of the urinarycatheter and incidence of VAP the percentage of 
present insertion urinarycatheter shows51.2% of neonates, but the percentage with the 
absence of the insertion of folly catheter is 48.8% of positive VAP. The test showsa 
relationship between the presence of insertion urinary catheter and positive VAP [χ2= 23.287, 
P-value = 0.000]. In this study, the researcher found that insertingurinary catheter 
isdeterminant of VAP among neonates. Concerning urinary catheter the researcher did not 
find any previous studies deal with it as a risk factor of VAP. So the researcher tends to 
examine its affects as determinant of VAP among neonates. According to literature 
review,urinary catheter is considered part of invasive devises. Many previous studies 
detected that enteral nutrition are determinants for VAP as they may increase the risk of 
gastric distention, colonization with gram-negative microorganisms to multiply in the 
 
 
46 
 
stomach, and consequently lead to an increased rate of neonatal pneumonia (NP). Though, 
to reduce the risk of NP, it is important to avoid unnecessary enteral nutrition. 
Table 4.5Distribution of cases according toblood administration 
 
Table 4.5 shows the results according to the blood administration and incidence of 
VAP.The percentage of yes blood administration is 67.4% of neonates, but the percentage 
of no blood administration is 32.6% of positive VAP. The test showsstrong relationship 
between yes blood administration and incidence of VAP [χ2= 14.989, P-value = 0.000], 
aswell as to the blood administration component that included (plasma, packed RBS,( 
plasma,  human albumin and  packed RBS)  and (plasma and packed RBS) ).  
For plasma component transfusion, the percentage reaches approximately 4.7% of positive 
VAP. For packed RBS component transfusion the percentage is 11.6%.The percentage 
reaches to 11.6% of positive VAP in (plasma, human albumin and packed RBS). For both 
(plasma, packed RBS) component transfusion, the percentage is 39.5% of positive VAP. 
The test clarifies that there is a strong relationship between blood transfusion and incidence 
of VAP [χ2= 22.105, P-value = 0.000]. That means increasing blood component 
transfusioncan increase the incidence of the VAP among neonates. Regarding the neonates 
Administration blood products 
Negative 
VAP 
Positive 
VAP χ2 
P-
Value 
No % No % 
Administration 
of blood 
products 
Yes 17 28.8 29 67.4 
14.989 0.000 
No 42 71.2 14 32. 6 
If yes 
administration 
blood products 
Plasma 7 11.9 2 4.7 
22.105 0.000 
Packed RBS 4 6.8 5 11.6 
Plasma & human 
albumin &  Packed 
RBS 
1 1.7 5 11.6 
Plasma & Packed RBS 6 10.2 17 39.5 
No administration 
blood products 
41 69.5 14 32.6 
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on M.V for more than 48 hours who didn't undergo any blood component transfusion, their 
percentage is approximately 32.6% of positive VAP. In addition,for blood products 
transfusion to neonates the researcher did not find any previous studies dealing with it as 
determinates of VAP in neonates. So he tends to examine its affect as a risk factor of VAP 
among neonates. Due to previous studies, blood products transfusion to neonates is 
considered part of invasive devises. 
Table 4.6Distribution of cases according to blood culture results 
Result of 
blood  culture 
Negative 
VAP 
Positive VAP  
χ2 
 
P-value 
No. % No. % 
Klebsilla 3 5.1 13 30.2 
54.830 0.000 
Acinetobacter 12 20.3 21 48.8 
Candida 0 0.0 3 7.0 
Pseudomonas 2 3.4 5 11.6 
Coagulase- 
negative 
staphylococci 
0 0.0 1 2.3 
Negative blood  
culture 
42 71.2 0 0.0 
 
Table 4.6 shows the results concerning blood culture sensitivity, the table (4.6) clarifiesthat 
the percentage of neonates who were diagnosed VAP byacinetobacter is 48.8%, byklebsilla 
is30.2%, by candidais 7.0%, by Pseudomonas is11.6%, by Coagulase- negative 
staphylococci reaches approximately 2.3%, and the percentage of neonates negative blood 
culture and positive VAP of neonates is0.0%. The test clarifies that there is a significant 
difference between positive VAP and negative VAP regarding the blood culture and the 
risk of developing VAP, the difference between positive VAP and negative VAP is 
statistically significant [χ2= 54.830, P-value = 0.000].That means that positive blood culture 
increase the incidence of the positive VAP increase among ventilated neonates of more 
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than 48 hours.This result is consistent with the results of a study conducted by Badr et al. 
(2011) in which microorganisms associated with blood stream infection in VAP diagnosed 
group were Klebsiella (15.6%), S. aureus (12.5%), Pseudomonas (9.4%), E. coli (6.2%), 
Candida (3.1%); 53.1% of obtained blood cultures were sterile. Also this result is 
inconsistent with a study conducted in Indian showed that blood culture has limited value 
in microbiological diagnosis of VAP. Endotracheal aspiration (ETA) shows 45% positive 
culture while blood culture yields only 25.88% positive culture. Blood culture may be 
useful for finding extra pulmonary source of infection associated with VAP (Santosh, 
2016).  
Table 4.7Distribution of cases according toneonatal profile 
 
 
 
 
 
Table 4.7 shows the results concerning mode of delivery the survey is divide into two 
categories CS and NSVD.The incidence of VAP in the CS was 60.5% while the VAP 
incidence in the normal spontaneous vaginal delivery was 39.5%. The test clarifies that 
there is a significant difference between positive VAP and negative VAP regarding the 
mode of delivery and CSconstitutes a risk for developing VAP.The difference between 
positive VAP and negative VAP was statistically significant [χ2= 7.090, P-value = 
0.008].That means if neonates delivered CSand required to be put on MV more than 48 
hours the incidence of the VAP increases. This result is inconsistent with another study 
Variable 
Negative 
VAP 
Positive 
VAP 
 
χ2 
 
P-
value 
 
No % No % 
Mode of 
delivery 
Cesarean section 20 33.9 26 60.5 
7.090 0.008 
NSVD 39 66.1 17 39.5 
Birth 
weight 
Normal BWT 23 39.7 12 27.9 
1.505 0.220 
Low BWT 35 60.3 31 72.1 
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showsthat there were non-significant differences regarding mode of delivery and indication 
of NICU admission (Badr et al, 2011). 
According to birth weight the survey was divided into two categories: normal birth weight 
(2500g-4000g) and LBW that "less than 2500g".The incidence of VAP in normal birth 
weight is 27.9% while the incidence of VAP in the LBW reaches approximately to 72.1%. 
The test shows no relationship between the birth weight and the incidence of VAP 
[χ2=1.505, P-value = 0.220]. Is clear that 66 neonates from 102 of total neonates have 
LBW and only 35 neonates from 102 of total neonates have normal birth weight and that 
result in abnormal distribution in the sample. There is a difference between percentages but 
this difference is not significant because of the degree of p-value which reached to less 
than 0.05. The percentage of positive VAP in LBWis 72.1% as well as the percentage of 
positive VAP in normal birth weight is 27.9% of ventilated babies more than 48 hours.This 
result differed with other study by (Foglia et al, 2007).LBW has been shown to be a risk 
factor for the development of nosocomial pneumonia. A 41-month surveillance study 
demonstrated a significant association between a birth weight of <1,500 g and a higher rate 
of nosocomial pneumonia (48). However, LBW may be a marker for an increased duration 
of mechanical ventilation. 
4.2 Direct observation committing to principles of infection control in NICU 
The total direct observation checklist (30) that involve four hospitals AL- shifa hospital 12 
observations ,Al-Naser Hospital 10 observations ,AL-Tahreer Hospital 5 observations, 
andEUG 3 observations That was during one month started  from the 23
rd
 of June to 23
rd
 of 
July 2017. 
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Table 4.8 Direct observation of committing to principles of infection control in NICU 
 
 
 
Variable Hospitals No Mean Std F 
P-value 
 
Hand Washing 
EUG 3 75.0 25.0  
 
24.807 
 
 
0.000 
Al-Shifa Hospital 12 14.6 19.8 
Al-Naser Hospital 10 95.0 10.5 
AL-Tahreer 5 25.0 43.3 
Disinfectant 
tools of ETT 
EUG 3 91.7 14.4  
 
28.539 
 
 
0.000 
Al-Shifa Hospital 12 12.5 22.6 
Al-Naser Hospital 10 100.0 0.0 
AL-Tahreer 5 40.0 45.4 
Infection 
control 
procedures for 
the Suction 
process 
EUG 3 81.5 8.5  
 
10.851 
 
 
0.000 
Al-Shifa Hospital 12 49.1 9.4 
Al-Naser Hospital 10 72.8 13.7 
AL-Tahreer 5 45.6 19.8 
Infection 
control Polices 
EUG 3 86.7 23.1  
 
5.774 
 
 
0.004 
Al-Shifa Hospital 12 43.3 28.1 
Al-Naser Hospital 10 88.0 19.3 
AL-Tahreer 5 60.0 37.4 
Infection 
control Kits 
EUG 3 53.3 23.1  
 
1.717 
 
 
0.188 
Al-Shifa Hospital 12 81.7 13.4 
Al-Naser Hospital 10 68.0 21.5 
AL-Tahreer 5 72.0 33.5 
Total 
EUG 3 78.7 7.0  
 
17.972 
 
 
0.000 
Al-Shifa Hospital 12 44.9 7.5 
Al-Naser Hospital 10 79.7 9.5 
AL-Tahreer 5 48.3 25.0 
Total 30 60.5 20.7 
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Table 4.1 shows that the directobservation checklist to examine the commitment  to 
principles of infection control in NICU in four hospitals that involve AL- shifa hospital, 
Al-Naser Hospital, AL-Tahreer Hospital and Finally EUG. Table (4.8) shows that there is 
statistically significant differences between all hospitals above concerning hand washing (F 
=24.807, P-value = 0.000), the differences are: for Al-Naser Hospital the mean is 95.0% 
followed by EUG 75.0% while the lowest mean is for AL- shifa hospital with the mean of  
14.6% followed by AL-Tahreer Hospital with mean of 25%.Routine hand washing is one of 
the most importantstrategies to reduce nosocomial infections. In a2-year-long surveillance 
intervention with NICU patients,increased hand hygiene compliance (from 43 to80%) and 
that significantly reduced the incidence of respiratoryinfections from 3.35 to 1.06 
infections per 1,000 patientdays(Cernada et al, 2014). On the other handthere is a 
statistically significant differences between disinfectant tools of ETT and hospitals (F 
=1.717, P-value = 0.000), the differences are: for Al Naser Hospital the mean is 100.0% 
followed by EUG 91.7% while the lowest mean is Shifa Hospital 12.5%.. According to 
infection control procedures for the Suction process there is a statistically significant 
differences between infection control procedures for the Suction process and hospitals (F 
=10.851, P-value = 0.000), the differences are for EUG the  mean is 81.5% followed by Al 
Naser Hospital while the lowest mean was AL-TahreerHospital with mean of 45.6%. 
Endotracheal suctioning is used for eliminating bronchopulmonary secretions from the 
airway. Traditional open endotrachealsuction requires disconnection from the ventilator 
but now allowed endotrachealsuctioning without disconnection from the ventilator that 
called closed endotracheal suction systems (Foglia et al, 2007). 
For Infection control Polices there is a statistically significant differences between 
infections control Polices and hospitals (F =5.774, P-value = 0.004).The differences are: 
for Al Naser Hospital the mean is 88.0% followed by EUG 86.7% while the lowest mean is 
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Shifa Hospital 43.3%. Concerning infection control Kits and supplies there is no 
statistically significant differences between Infection control Kits and hospitals (F =28.539, 
P-value = 0.188). Moreover educational interventions for Infection control Polices and 
efforts to improveadherence to hand hygiene have been associated with decreasedVAP 
rates(Foglia et al, 2007). 
According to commit to principles of infection control in NICU there are 
statisticalsignificantdifferences between hospitals (F =17.972, P-value = 0.000),the 
differences are: forAl Naser Hospital, themean is 79.7% followed by EUG 78.7% while the 
lowest mean is ShifaHospital 44.9% followed byAL-Tahreer48.3%, although Shifa and AL-
Tahreer are the main health care provider in NICU. 
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Chapter (5) Conclusion and Recommendation 
This chapter provides the main conclusion and the recommendation for the health care 
provider and decision makers to recognize the risk factors concerning theincidence of VAP 
among neonates and to provide suggestion aiming to reduceit. 
In order to improve the health of Palestinian neonates, it is expected that we can reduce 
morbidity and mortality by restricted the useof invasive devises in general,ULC, chest 
tube, urinary catheter, and necessity of blood transfusion sterility of any components, in 
addition toreducing the duration of intubation from ventilated babies,prevention protocols 
"health policies", programs and regulations that reduce exposure to these 
determinates.However, it is important to know the number of illnesses and deaths caused 
by each determinant before developing polices aim to improve public health.Reducing 
morbidity and mortality need cooperation and shared responsibilities with different 
governmental and non-governmental institutions to promote healthy procedures. 
5.1 Conclusion 
According to the results of this study, the researcher can conclude that different 
determinants could affect the health status of the neonates in GG and lead to VAP. These 
determinantsinclude neonatal, intubation profile, sensitivity of BAL culture and invasive 
devises. The researcher can conclude that the reduction of these determinates such as 
prolonged period of intubation, preterm deliveries, insert Ryle feeding, elective CS 
delivery, limited any component of blood transfusion, decrease times of ETT change will 
help in reducing the morbidity and mortality of neonates with VAP in GG. I suggest to 
train and supervise the health care team to comply with infection control protocols, in 
addition to give training course to the health care team,to use disposable 
ventilatorcircuits,to avoid unnecessary ULC, to use sterile chest tube and closed suction 
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proceduresand other invasive procedures. Finally, BAL cultures for early diagnosisof VAP 
should be used extensively.  
5.2 Recommendations 
According to the results of the current study, the following recommendations are 
suggested: 
1. Implementingfuture researches about VAP problems in neonates toaccurately 
determine the morbidity and mortality of these problems in GG and estimate 
incidence of VAP among neonates. 
2. Improving utilization of the CDC's protocol of respiratory infections will help in 
reducing the incidence of VAP in GG. 
3. Using of aseptic technique to insertion of Ryle tubeespecially in ventilated babies. 
4. Necessity of blood transfusion sterility of any components principally in ventilated 
babies. 
5. A general rule, patients should be extubated as soon as possible is a main strategy to 
prevent VAP introducing. 
6. Transferring the neonates who diagnosed VAP to isolation room at least 24 hours. 
7. Activating the role of infection control committee to observe invasive devises 
procedures to reduce infection in NICU. 
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Annexes 
Annex (1) Map of Palestine 
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Annexes (2) Distribution of Hospital in Gaza Strip 
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Annexes (3) Al-Quds University Approval Latter 
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Annexes (4) MOH Approval Latter (Al-Shifa Hospital) 
 
 
 
 
 
 
64 
 
Annexes (5) MOH Approval Latter (Al-NaserPediatric Hospital) 
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Annexes (6) Helsinki CommitteeApproval Latter 
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Annexes (7) Cover Letter and Consent Form 
Cover Latter 
Determinants of Ventilator-associated Pneumonia among Neonates-Gaza 
Governorates cross sectional study 
 
 
Dear Dr. 
This study is conducted as a part of the requirement for the Master Degree in 
Public health at Al-Quds University. 
General objective: 
To assess main determinates for development ofVAP among neonates in Gaza 
Governorates. Thus the study findings may contribute to estimate the 
incidence rate of neonatal VAP in ICU in Gaza governorates.  To achieve the 
objectives of this study, the researcher built direct observation checklist sheet 
through reviewed literatures and previous studies. 
Kindly, read the direct observation checklist, give your opinion and write your 
suggestion. Certainly, your advice and suggestions will contribute to achieve the 
research objectives. 
 
Sincerely, 
Abedalla Mahdi 
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Annexes (8)Firstobservation checklist sheet 
1.  Neonatal information 
1.3 Serial number 1.2Date of admission---\---\----- 1.1 Gender Male            female 
1.4 AddressGaza city           North Gaza            Middle zone  Khan YounisRafah 
1.5 Hospital name 
       AL- Shifa Hospital              Khan Younis Hospital             Al-Naser pediatric Hospital          
European Gaza Hospital 
2. Neonatal profile 
2.1 Gestational age 
  Premature                      Full term                                  Post term 
2.1.1 If the patient premature how many of gestational age ---------- weeks. 
2.2 Birth weight: ----------------- KG. 
2.3 Type of delivery 
 C.S.                            NVD                        Vacuum                  Forceps 
3. Intubation profile 
 3.1 Length of intubation 
                                      Between 48-72hr                        72-120hr                                      More than 120hrs 
3.2 How many times endotracheal tube was changed ------------time/s 
4. Bronchoalveolar lavage culture and sensitivity profile 
4.1 Results of the BAL cultures 
 Positive culture                         Negative culture 
4.1.1If culture positive determine                 
 Gram-positive                    Gram-negative 
4.2.1 Name of the causative microorganism -------------------   
5. Invasive devices profile 
5.1 Chest tube present              
 yes                         No 
5.2 Umbilical line catheter  present         
  yes                        No 
5.3 urinary catheter present          
  yes                       No 
5.4 Ryle tube present             
 yes                      No 
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5.5 Administration blood products  
 yes                       No 
5.5.1 If yes                 Plasma               Pocket RBS                Human albumin 
6. Chest x-ray 
6.1 How many chest x-ray was  perform before intubation process    --------------time\s  
 6.2 How many chest x-ray was  perform after  intubation process  ----------time\s   
6.2.1 Chest x-ray result 
Chest  infiltration in the chest x-ray 
  Yes                                       No 
7. Clinical sings of neonates 
7.1 Heart rate by monitors measurement ----------------- beats/min 
7.2 Body temperatures for neonate by thermometer  -------------- c˚  
7.3 Respiratory rate for neonate by monitors measurement -------------- breath/min 
7.3.1 Neonates enter apnea          
  yes                                     No 
7.3.2 How many time ----------- time\s  
Medical diagnosis of neonates8. 
8.1 medical Cause of admission    
 Respiratory distress                                 Birth asphyxia                                       Sepsis 
  Premature                                                 Congenital anomalies                        others 
Laboratory test 9. 
9.1 Complete blood count Result  
    Red blood cells --------------ML    White blood cells ------------ ML  Platelet ------------- 
MLHemoglobin------------DL    
9.2 Arterial blood gases result 
 PH -----------  
 PaO2 mmHg ----------  
 PaCo2 ---------- 
9.3 Blood culture results 
 Negative                                Positive  
 9.3.1 If results positive 
 Gram-positive                       Gram-Negative   
 9.3.2 causative microorganism ------------------------- 
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Annex (9) List of expert's names who reviewed the study Observation checklist sheet: 
 
Name Position 
Dr. Yehia Abed Al Quds University 
Dr. Khitam Abu Hamad Al Quds University 
Dr. Shereen Abed MOH- Al Nasser pediatric hospital 
Dr. Allam Abu Hamda MOH- AL- Shifa Hospital 
Dr. Hanan Alwadea MOH- AL- Shifa Hospital 
Dr. Mohammad Shubair Islamic University 
Mr. Ahmed Afifi MOH- Al Nasser pediatric hospital 
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 teehs tsilkcehc noitavresbo dnoceS )01( sexennA
 إذا الجواب هو نعم  لا نعم البيان الرقم
 اذكر بالتفصيل
 غسل اليدين : المحور الأول
عملية التشفيط  للمولود الجديد المرتبط بجهاز  غسل اليدين قبل يتم هل  .1
 .التنفس الصناعي 
   
عملية التشفيطللمولود الجديد  المرتبط بجهاز هل  يتم غسل اليدين بعد   .2
 .التنفس الصناعي 
   
    .هل يتم غسل الأيدي في حالة التعامل مع المريض الواحد لأكثر من تدخل  .3
    .بالشكل الصحيح حسب منظمه الصحة العالمية اليدينهل يتم غسل   .4
 .)TTE(نظافة الأدوات الازمة لعملية تثبيت : المحور الثاني
    ).TTE(تم استخدامها في تثبيت يهل يتم تنظيف وتطهير الأدوات التي   .5
    .هل يتم تنظيف أجهزة التنفس الصناعي بمادة مطهرة  .6
    .بمادة مطهرةpocsognyralمعدات هل يتم تنظيف  .7
    .بمادة مطهرة بعد كل مريض  ksaM gaB ubmAتنظيف هل يتم   .8
 إجراءات ضبط العدوى لعملية التشفيط: المحور الثالث
    .هل يتم ارتداء القفازات المعقمة بشكل صحيح  .9
    )noitcennoc noitcuS(بعد خروج المرضى هل يتم تغير أنابيب الشفط   .11
  .11
يتم استخدام مقاس أنبوب الشفط المناسب للمولود الجديد المرتبط علي هل 
 .جهاز تنفس صناعي
   
  .21
هل يتم  اعادة استخدام أنبوب الشفط المناسب للمولود الجديد المرتبط علي 
 .جهاز تنفس صناعي أكثر من مرة
   
  .31
 noitcuS(بعد خروج المرضى أنابيب الشفط  إعادةتعقيم هل يتم
 )noitcennoc
   
    .أثناء وجود المرضى هل يتم وضع مادة مطهرة داخل مخزن جهاز الشفط  .41
  .51
داخل مخزن ) بدون إضافة مواد مطهرة (ماء مقطر فقط هل يتم وضع 
 .أثناء وجود المرضى جهاز الشفط
   
    .من أي سوائلبعد خروج المرضى مخزن جهاز الشفطإفراغ هل يتم   .61
    .بطريقة معقمة) noitcuS(هل يتم إجراء عملية الشفط   .71
ثواني عند التشفيط للمولود الجديد )  9-8(هل يتم الالتزام بالزمن المحدد من   .81
 .المرتبط علي جهاز التنفس الصناعي
   
قبل البدء بعملية ) )08-021من   ) erusserp noitcus (هل يتم ضبط   .91
 .التشفيط للمولود الجديد المرتبط علي جهاز التنفس الصناعي
   
للمولود الجديد المرتبط  TTEهل يتم استخدام  الحجم المناسب  لتركيب   .12
 .علي الجهاز التنفس الصناعي
   
   خلال عملية ) %9.0 enilas lamroN(محلول ملحي  عند استخدام  .12
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 .هل يتم تحضير المحلول بطريقة معقمة, الشفط
    .هل يتم التأكد من صلاحيات المحلول الملحي  .22
    . هل يتم التأكد من تاريخ انتهاء صلاحية المواد المعقمة قبل الاستخدام  .32
  .42
هل يتم تغيير جهاز ترطيب الهواء بجهاز التنفس الصناعي بعد خروج 
 .الحالات
   
    .بعد خروج المرضى هل يتم تغيير أنابيب جهاز التنفس الصناعي  .52
  .62
هل المستلزمات والادوات اللازمة للالتزام بإجراءات ضبط العدوى متوفرة في 
 . القسم بشكل كافي
   
 سياسات ضبط العدوى: المحور الرابع
    )eniL lacilibmU(هل هناك سياسة مكتوبة للقسطرة الوريدية المركزية   .1
 
المكتسب من الجهاز  هل هناك سياسة مكتوبة لمنع عدو الجهاز التنفسي
 .التنفس الصناعي
   
  .2
الحالات المصابة بالالتهابات  هل هناك سياسة مكتوبة عن إجراءات عزل
 .الجهاز التنفس المكتسب من جهاز التنفس الصناعي
   
 
المكتسب من الجهاز  هل يتم رصد وا  حصاء حالات التهاب الجهاز التنفسي
 .التنفس الصناعي
   
    .سياسات ضبط العدوىهل يتلقى الطاقم دورات تدريبية أو محاضرات حول  
 .مستلزمات ضبط العدوى: المحور الخامس
    .هل يتوفر صابون سائل 
    .هل يتوفر صابون معقم 
    .هل يتوفر كحول 
    . bur dnahهل يتوفر جهاز  
    .هل يتوفر منشفة ورقية 
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Annex (11) List of expert's names who reviewed the study Observation checklist sheet: 
 
Name Position 
Dr. Yehia Abed Al Quds University 
Dr. Anwar Alshaikhkhalil 
Consultant Pediatrician and Neonatologist- 
Islamic University 
Dr. Khitam Abu Hamad Al Quds University 
Dr. Shereen Abed MOH- Al Nasser pediatric hospital 
Dr. Allam Abu Hamda MOH- AL- Shifa Hospital 
Dr. Hanan Alwadea MOH- AL- Shifa Hospital 
Dr. Mohammad Shubair Islamic University 
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 tcartsba cibarA )21( xennA
 الدراسة ملخص
محددات الالتهابات الرئوية التي لها علاقه بالجهاز التنفسي الصناعي بين حديثي الولادة 
 في محافظات غزة 
 عبدالله رفيق مهدي : الباحث
 يوسف عوض. د: إشراف
 مقدمة
 هي الالتهابات الرئوية:مركزالسيطرةعلىالأمراضالالتهابات الرئوية المرتبطة بالجهاز التنفس الصناعي حسب 
 .جهاز تنفس صناعي ساعة من وصل المريض على 48التي تحدث عند المريض بعد مرور أكتر من 
الالتهابات الرئوية المرتبطة بجهاز التنفس الصناعي تعتبر في المرتبة الثانية من الالتهابات المكتسبة من 
 . و المواليد الجددسواء في الاطفال أ, داخل المستشفيات 
حدوث التهاب مبكر يحدث في أول : إلىقسمين الرئوية المرتبطة بجهاز التنفس الصناعيتنقسم الالتهابات 
أما . النوع يستجيب للمضادات الحيوية وهذا,الصناعيجهاز التنفس  من وصل المريض علىيام أربعة أ
جهاز التنفس  التهابات متأخرة تحدث بعد خمسه أيام من وصل المريض على هو حدوثالقسم الثاني 
غياب المعايير الذهبية لتشخيص  ظم المضادات الحيوية بالإضافة إلىوهذا النوع مقاوم لمع, اعيالصن
 .وخاصة عند المواليد الجدد، مرض الالتهاب الرئوي المرتبط بجهاز التنفس الصناعي
هنالك العديد من المحددات ارتبطت بشكل مباشر في حدوث الالتهاب الرئوي المرتبط بجهاز التنفس  
حيث إنها تعتبر واحدة من أهم طول فترة وضع المواليد الجدد علي جهاز التنفس الصناعي ؛ منها اعيالصن
وكذلك أيضًا , الولادة  يعلي حديث الرغامي المركبنبوب بالإضافة إلى عدد مرات تغيير الأ, العوامل هذه 
 .نقل أي من مركبات الدم إلىحديثي الولادة
 :  أهداف الدراسة
لناجين بين اما معرفة المحددات التي أدت إلى حدوث الالتهابات الرئوية المرتبطة بجهاز التنفس الصناعي  
 .والمصابين بهذا النوع من الالتهاب
القسطرة البولية، القسطرة السرية، (معرفة العلاقة بين الإجراءات المستخدمة النافذة لجسم حديثي الولادة  
وحدوث الالتهابات الرئوية ) الأنبوب البلوري الصدري، ونقل أحد مكونات الدمالتغذية عن طريق الأنابيب، 
 . المرتبطة بجهاز التنفس الصناعي
 . منالالتهابات الرئوية المرتبطة بجهاز التنفس الصناعي وأثارها على حديثي الولادةتحديدالمحدداتالأكثرشيوعا ً 
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بالالتهابات الرئوية المرتبطة بجهاز التنفس الصناعي لاتخاذإجراءاتللحدمنالإصابة تقديم اقتراحات وتوصيات 
 .فيمحافظاتغزة في أقسام العناية المركزة  علىصحةحديثيالولادةبوحدةالحضانة
 
 منهجية الدراسة
  ,2116أغسطس  11و  2116مايو  1وهي دراسة واقعة ما بين  دراسة وصفية تحليلية، هذه الدراسة
 . يوم 111درست الحالات المرضية خلال فترة حيث 
 عينة الدراسة 
 ، )حالة 48(مستشفى الشفاء (: مستشفيات 8حالة مرضية موزعة على 611تكونت عينة الدراسة من 
،  ))حالات9(،  مستشفى غزة الأوروبي )حالة 16(مستشفى النصر للأطفال ، )حالة26(خانيونس  مستشفى
على جهاز تنفس  وموصولون, ًا يوم 46ي مواليد جدد تقل أعمارهم عن مع العلم أن جميع الحالات ه
ساعة،  وقد تم تشخيصهم من قبل الباحث والأطباء معًا من خلال صور الأشعة  48صناعي لأكثر من 
فحص : (وقد قام الباحث بمراقبة العلامات الحيوية وعمل فحوصات وهي ,ا ًرئوي ا ًلتهاباجد أن فيهاوو  العادية 
،  وعينة غازات الدم،  عمل مزرعة للإفرازات والسوائل الموجودة في الأنبوب الرغامي،  )CBC(الدم الكامل 
 ).وعمل مزرعة للدم
 كيفية جمع البيانات
إعداد  هذه الأداة لهذا الغرض وهي من ممتحيث ص  المراقبة المباشرة للمريض؛ معت البيانات من خلال ج  
العلامات الحيوية  للمولود، المعلومات الشخصية:منهاعديدة الباحث، وشملت هذه المراقبة المباشرة مجالات 
للفريق والخصائص الصحية والعادات السلوكية ,ونتائج الفحوصات والتحاليل الطبية الخاصة بكل مريض, 
ل عدد مرات تغيير الأنبوب الرغامي ومدة وضع المولود على جهاز الصحي عند التعامل مع المريض مث
 بالإضافة الى أداة جديدة من خلال المراقبة المباشرة وهي مبادئ الالتزام بضبط العدوي التنفس الصناعي،
من قبل المحكمين بالإضافة لتطبيق الملاحظة  تين السابق ذكرهما وذلكوقد تم فحص صدق وثبات الأدا
 . كما التزم الباحث بالمعايير الأخلاقية البحثية. بالدراسة على عينة استطلاعية قبل البدءرة المباش
 تحليل البيانات
حيث تم   لمعالجة البيانات إحصائياً؛" SSPS"تم استخدام برنامج الرزم الإحصائية للعلوم الإجتماعية 
 . المحددات،  لفحص العلاقة بين AVONA، eulav-P ، erauqs-ihCاختبار النتائج باستخدام، 
 هم النتائجأ
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بالالتهابات  يكون لها الأثر المباشر في الإصابةهاسعتقد بأني  المحددات والتي  هذه الدراسة العديد منبينت 
 : ،والتي يمكن التحكم بها وكان لها دلالة إحصائية وهيالرئوية المرتبطة بجهاز التنفس الصناعي
بلغ معدل الإصابة بمرض الالتهاب الرئوي المرتبط بجهاز التنفس الصناعي عند المواليد حديثي الولادة في  
، حيث كان مستشفى الشفاء أعلى نسبة إصابة حيث %6.68حوالي يوم  111خلال فترة محافظات غزة 
تشفى غزة ، وأخيرًا مس%2.41، يليه مستشفى النصر %6.42، يليه مستشفى خانيونس %9.18بلغت 
 %. 2.6الأوروبي 
والأنبوب  بالاضافة الى وجود القسطرة البولية نقل الدم ومكوناتهاسة أن التغذية ممن خلال الأنبوبو وجدت الدر  
أكثر محددات الإصابة بمرض الالتهاب الرئوي من هي  )ebut tsehc(المثبت في التجويف الصدري 
يثي الولادة في الإجراءات المستخدمة النافذة لجسم حديثي المرتبط بجهاز التنفس الصناعي عند المواليد حد
 .  الولادة
ساعة يزيد من  161وجدت الدراسة أن طول فترة مكوث المولود على جهاز التنفس الصناعي لأكثر من  
 .فرص حدوث الإصابة بمرض الالتهاب الرئوي المرتبط بجهاز التنفس الصناعي عند المواليد حديثي الولادة
من أكثر محددات الإصابة بمرض الالتهاب الرئوي المرتبط بجهاز  موجبةالدراسة أن مزرعة الدم ال وجدت 
 . التنفس الصناعي عند المواليد حديثي الولادة
بينت الدراسة أن الولادة القيصرية والولادة الطبيعية الصعبة تزيد من محددات الإصابة بمرض الالتهاب الرئوي  
 .الصناعي عند المواليد حديثي الولادةالمرتبط بجهاز التنفس 
 
 التوصيات
 :من أهم التوصيات التي خرجت بها هذه الدراسة
 .وضعقاعدةبياناتوطنيةلضماندقة السجلات الطبية بشكل عام وخاصة عن المواليد حديث الولادة فيفلسطين 
اعي عند المواليد حديثي المزيدمنالأبحاثحولمشكلةمرض الالتهاب الرئوي المرتبط بجهاز التنفس الصنإجراء 
 .لمراضة والوفياتمنهذهالمشكلةفيفلسطينالولادة للوصول إلى معدلات دقيقة ل
 .تقليلالولاداتالقيصريةالاختياريةوخاصةفيالمراكزوالمستشفيات الخاصة 
الاستفادةمنبروتوكولمركزالسيطرةعلىالأمراضالتهاباتالجهازالتنفسييساعدفيالحدمنحدوثمرض الالتهاب الرئوي  
 .المرتبط بجهاز التنفس الصناعي عند المواليد حديثي الولادة في محافظات غزة
 .تطبيقالدراساتالمستقبليةحولقسمضبط التحكم وتقليل العدوى 
تقليل استخدام التغذية عن طريق الأنبوب خاصةفيالمواليد التي تطول فترة مكوثهم على أجهزة التنفس  
 .الصناعي قدر الإمكان
 .الأنبوب الرغامي قدرالإمكان أو عند الضرورة التقنين من تغيير 
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 .التقنين في نقلأيمنمكوناتالدمللمواليد حديثي الولادة قدرالإمكان 
خصوا بمرض الالتهاب الرئوي المرتبط بجهاز التنفس الصناعي في وضع المواليد حديثي الولادة الذين ش   
 .ساعة 86 غرفةالعزلفيما لا يقلعن
 .فيمحافظاتغزة)eldnuB PAV(اليةتقديمدراساتعاجلةلتقييمفع 
تفعيل التثقيف الصحي للكادر الصحي العامل في أقسام العناية المركزة لحديثي الولادة عن طرق الوقاية  
 . والعلاج خصوصًا للالتهاب الرئوي المرتبط بجهاز التنفس الصناعي عند المواليد حديثي الولادة
 
